Literature DB >> 10097412

Expression of functionally P-glycoprotein in MA104 kidney cells.

M A Capella1, M Orind, M M Morales, V M Rumjanek, A G Lopes.   

Abstract

Rhesus monkey kidney MA104 cells are a polarized epithelium with some unusual characteristics, including a resistance to ouabain, although their Na(+)-K(+)-ATPase has normal affinity with this drug. This work suggests that MA104 cells have high expression of functionally P-glycoprotein in their membranes. This was established using four complementary methods to investigate the expression and function of P-glycoprotein in these cells. MA104 cells were strongly resistant to vincristine, which could be reversed by three known P-glycoprotein modulators: verapamil, cyclosporin A and trifluoperazine. In addition, MA104 cells accumulate little rhodamine 123, and the incubation with verapamil increased this accumulation. The mdr1-mRNA was detected by reverse transcription-polymerase chain reaction and a subcloned 283-bp product was identified. Its nucleotide sequence was compared with the related region of human mdr1, showing a high identity (96%) between the two sequences. The expression of P-glycoprotein in the cell membrane was observed by Western blot and immunofluorescence. The results taken together suggest that MA104 cells intrinsically have a high expression of functionally P-glycoprotein in their membranes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10097412

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  2 in total

1.  P-glycoprotein-like protein contributes to cadmium resistance in Euglena gracilis.

Authors:  M Einicker-Lamas; M M Morales; K Miranda; J Garcia-Abreu; A J F Oliveira; F L S Silva; M M Oliveira
Journal:  J Comp Physiol B       Date:  2003-07-22       Impact factor: 2.200

2.  ABCC1 is related to the protection of the distal nephron against hyperosmolality and high sodium environment: possible implications for cancer chemotherapy.

Authors:  Leonardo M Fonseca; Adriana B Alvarez; Rachel C Rodrigues; Diego H F Santos; Anibal G Lopes; Marcia A M Capella
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.